Faulty Serotonin--dhea Interactions in Autism: Results of the 5-Hydroxytryptophan Challenge Test.

Jan Croonenberghs,Kristien Spaas,Annick Wauters,Robert Verkerk,Simon Scharpe,Dirk Deboutte,Michael Maes
2008-01-01
Abstract:BACKGROUNDAutism is accompanied by peripheral and central disorders in the metabolism of serotonin (5-HT). The present study examines plasma dehydroepiandrosterone-sulphate (DHEA-S) and the cortisol/DHEA-S ratio following administration of L-5-hydroxytryptophan (5-HTP), the direct precursor of 5-HT, to autistic patients.METHODSPlasma DHEA-S levels were determined both before and after administration of 5-HTP or placebo, on two consecutive days in a single blind order in 18 male autistic patients and 22 matched healthy controls.RESULTSThe 5-HTP-induced DHEA-S responses were significantly higher in autistic patients than in controls. In baseline conditions, the cortisol/DHEA-S ratio was significantly higher in autistic patients than in controls.DISCUSSIONThe results suggest that autism is accompanied by a major disequilibrium in the serotonergic system. The increased Cortisol (neurotoxic) versus DHEA-S (neuroprotective) ratio suggests that an increased neurotoxic potential occurs in autism.CONCLUSIONSIt is concluded that a disequilibrium in the peripheral and central turnover of serotonin and an increased neurotoxic capacity by glucocorticoids are important pathways in autism.
What problem does this paper attempt to address?